Rocket Fuel
Advanced Search
Print    Email
Decrease (-) Restore Default Increase (+)
Find a Physician

Lung Cancer Clinical Trials

Please check with your doctor or call 1-855-HCH-HOPE (424-4673) to find out if you qualify.

Trial  #

Trial Sub-type



First-line treatment advanced non-squamous non-small cell lung cancer

A Phase 3 Randomized, double-bling study of PF-06439535 plus Paclitaxel-carboplatin and Bevacizumab plus Paclitaxel-carboplatin for the first-line treatment of patients with advanced non-squamous non-small cell lung cancer

ECOG E 5508


IIIB or IV Stage Non-Squamous Non-Small Cell Lung Cancer

Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed or Both Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Stage Non-Squamous Non-Small Cell Lung Cancer. 

SWOG S0819


Stage IV

A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC). 

 CALGB 140503

 Non-Small Cell Lung Cancer

 A Phase III Randomized Trial of Lobectomy versus Sublobar Resection for Small (<=2 cm) Peripheral Non-Small Cell Lung Cancer. 

  Holy Cross Hospital
  Holy Cross Germantown Hospital

© 2016  Holy Cross Health | 1500 Forest Glen Road, Silver Spring, MD 20910 | 301-754-7000